in vitro PHARMACOLOGY 2011 CATALOG - Cerep
in vitro PHARMACOLOGY 2011 CATALOG - Cerep
in vitro PHARMACOLOGY 2011 CATALOG - Cerep
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
45<br />
leukotrienes ❚<br />
CysLT 2 (LTC 4 )<br />
cellul ar<br />
Ref. 2051 Agonist effect<br />
Ref. 2052 Antagonist effect<br />
Q 3 weeks<br />
Source<br />
human recomb<strong>in</strong>ant (HEK-293 cells)<br />
Measured product <strong>in</strong>tracellular [Ca 2+ ]<br />
Detection method fluorimetry<br />
Agonist effect Control LTC 4 (300 nM)<br />
Reference LTC 4 (EC 50 : 18 nM)<br />
Antagonist effect Stimulant LTC 4 (100 nM)<br />
Reference unavailable<br />
Takasaki, J. et al. (2000) Biochem. Biophys. Res. Commun., 274: 316-322.<br />
Ca 2+ mobilization (% of control)<br />
100<br />
50<br />
0<br />
-11 -10<br />
LTC4<br />
LTD4<br />
LTB4<br />
-9 -8 -7 -6<br />
log [agonist] (M)<br />
[Solvent] must be kept ≤ 0.1%<br />
antagonist effect:<br />
no graph available<br />
<strong>Cerep</strong><br />
services<br />
<br />
Receptors<br />
[GPCRs]<br />
-11 -10<br />
-9 -8 -7 -6 -5 -4<br />
-12 -11<br />
-10 -9 -8 -7<br />
-11 -10<br />
-9 -8 -7 -6 -5 -4<br />
-12 -11 -10 -9 -8 -7 -6 -5 -4 -3<br />
-12 -11<br />
-12 -11<br />
-10 -9 -8 -7<br />
-10 -9 -8 -7 -6 -5<br />
Ion<br />
channels<br />
-9 -8 -7 -6 -5<br />
-10 -4<br />
❚ Lysophospholipid<br />
Transporters<br />
LPA 1 - agonist radioligand<br />
Source<br />
human recomb<strong>in</strong>ant (CHO cells)<br />
❚ lysophosphatidic acid<br />
Ligand<br />
[ 3 H]LPA (2 nM)<br />
b<strong>in</strong>d<strong>in</strong>g<br />
Kd<br />
19 nM<br />
Ref. 1468<br />
Non specific LPA (10 µM)<br />
Q 3 weeks<br />
Reference LPA (IC 50 : 42.5 nM)<br />
Included <strong>in</strong>:<br />
Organ safety profile<br />
An, S. et al. (1997) Biochem. Biophys. Res. Commun., 231: 619-622.<br />
specific b<strong>in</strong>d<strong>in</strong>g (% of control)<br />
100<br />
50<br />
0<br />
LPA<br />
phosphatidic acid<br />
SEW 2871<br />
S 1P<br />
-10 -9 -8 -7 -6 -5 -4<br />
log [drug] (M)<br />
K<strong>in</strong>ases<br />
Epigenetic &<br />
DNA-related<br />
enzymes<br />
LPA 2<br />
❚ lysophosphatidic acid<br />
cellul ar<br />
Ref. 3171 Agonist effect<br />
Ref. 3172 Antagonist effect<br />
Q 3 weeks<br />
Source<br />
human recomb<strong>in</strong>ant (CHO cells)<br />
Measured product <strong>in</strong>tracellular [Ca 2+ ]<br />
Detection method fluorimetry<br />
Agonist effect Control LPA (1 µM)<br />
Reference LPA (EC 50 : 3.5 nM)<br />
Antagonist effect Stimulant LPA (30 nM)<br />
Reference unavailable<br />
Heise, C.E. et al. (2001) Mol. Pharmacol., 60: 1173-1180.<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
1<br />
<br />
[Solvent] must be kept 0.3%<br />
<br />
<br />
Other<br />
enzymes<br />
Specialized<br />
cellular<br />
assays<br />
<br />
LPA 3<br />
❚ lysophosphatidic acid<br />
cellul ar<br />
Ref. 3158 Agonist effect<br />
Ref. 3170 Antagonist effect<br />
Q 3 weeks<br />
Source<br />
human recomb<strong>in</strong>ant (CHO cells)<br />
Measured product <strong>in</strong>tracellular [Ca 2+ ]<br />
Detection method fluorimetry<br />
Agonist effect Control LPA (1 µM)<br />
Reference LPA (EC 50 : 6.4 nM)<br />
Antagonist effect Stimulant LPA (30 nM)<br />
Reference VPC 32183 (IC 50 : 3.9 µM)<br />
Heise, C.E. et al. (2001) Mol. Pharmacol., 60: 1173-1180.<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
1<br />
<br />
<br />
[Solvent] must be kept 0.3%<br />
Standard<br />
profiles<br />
Test<strong>in</strong>g<br />
conditions<br />
S 1 P 1<br />
❚ sph<strong>in</strong>gos<strong>in</strong>e 1-phosphate<br />
cellul ar<br />
Ref. 3269 Agonist effect<br />
Ref. 3271 Antagonist effect<br />
Q 3 weeks<br />
Source<br />
human recomb<strong>in</strong>ant (CHO cells)<br />
Measured product impedance<br />
Detection method cellular dielectric spectroscopy<br />
Agonist effect Control S 1 P (300 nM)<br />
Reference S 1 P (EC 50 : 4 nM)<br />
Antagonist effect Stimulant S 1 P (10 nM)<br />
Reference VPC 23019 (IC 50 : 150 nM)<br />
Davis, M.D., et al. (2005) J. Biol. Chem., 11: 9833-9841.<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
[Solvent] must be kept 0.1%<br />
Order<strong>in</strong>g<br />
<strong>in</strong>formation<br />
Assay list<br />
& <strong>in</strong>dex